88 related articles for article (PubMed ID: 4374772)
1. [Angiotensin blockade and hypertension].
Stenbaek O
Tidsskr Nor Laegeforen; 1974 Dec; 94(34-36):2396-7. PubMed ID: 4374772
[No Abstract] [Full Text] [Related]
2. Editorial: Angiotensin inhibition.
Chobanian AV
N Engl J Med; 1974 Oct; 291(16):844-5. PubMed ID: 4371423
[No Abstract] [Full Text] [Related]
3. Renin release and ketamine-induced cardiovascular stimulation in the rat.
Tanaka K; Pettinger WA
J Pharmacol Exp Ther; 1974 Jan; 188(1):229-33. PubMed ID: 4358437
[No Abstract] [Full Text] [Related]
4. The effect of 1-sarcosine, 8-leucyl angiotensin II on the pressor effect of infused angiotensin II.
O'Connor GJ; Baranowski RL; Kurtzman NA
Arch Int Pharmacodyn Ther; 1974 May; 209(1):75-9. PubMed ID: 4370454
[No Abstract] [Full Text] [Related]
5. Use of angiotensin II antagonists in experimental hypertension.
Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
[No Abstract] [Full Text] [Related]
6. Letter: Antagonism of central dipsogenic and peripheral vasoconstrictor reponses to angiotensin II with Sar Ala8 angiotensin II in the conscious cat.
Cooling MJ; Day MD
J Pharm Pharmacol; 1973 Dec; 25(12):1005-6. PubMed ID: 4150284
[No Abstract] [Full Text] [Related]
7. Vascular permeability factor: dissociation from the angiotensin II induced pressor and drinking responses.
Vaughan ED; Gavras H; Laragh JH; Koss MN
Nature; 1973 Mar; 242(5396):334-5. PubMed ID: 4349236
[No Abstract] [Full Text] [Related]
8. The effect of angiotensin-II intravenous infusion on plasma renin activity and prostaglandins A, E, and F levels in the uterine vein of the pregnant monkey.
Franklin GO; Dowd AJ; Caldwell BV; Speroff L
Prostaglandins; 1974 May; 6(4):271-80. PubMed ID: 4369285
[No Abstract] [Full Text] [Related]
9. Inhibitory effects of central hypertensive activity of angiotensin I and II by 1-sar-8-ala-angiotensin II (saralasin acetate).
Solomon TA; Buckley JP
J Pharm Sci; 1974 Jul; 63(7):1109-13. PubMed ID: 4368826
[No Abstract] [Full Text] [Related]
10. A new class of angiotensin inhibitors: N-methylphenylalanine analogs.
Peña C; Stewart JM; Goodfriend TC
Life Sci; 1974 Apr; 14(7):1331-6. PubMed ID: 4363010
[No Abstract] [Full Text] [Related]
11. Editorial: Angiotensin blockade: new pharmacologic tools for understanding and treating hypertension.
Laragh JH
N Engl J Med; 1975 Mar; 292(13):695-6. PubMed ID: 235091
[No Abstract] [Full Text] [Related]
12. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
Ogihara T; Nakamaru M; Higaki J; Hata T; Kumagai A; Kumahara Y
Med J Osaka Univ; 1983 Sep; 34(1-2):21-5. PubMed ID: 6366501
[No Abstract] [Full Text] [Related]
13. A new class of angiotensin II analogs: substitution of sarcosine in position 7.
Moore G; Oudeman E; Gorman P
Proc West Pharmacol Soc; 1978; 21():261-6. PubMed ID: 693506
[No Abstract] [Full Text] [Related]
14. [The angiotensin II block in human malignant hypertension].
Scarpelli PT; Sproviero R; Corti C; Menniti P; Lamanna S; Saratti A
Boll Soc Ital Biol Sper; 1977 Nov; 53(22):2041-7. PubMed ID: 603709
[No Abstract] [Full Text] [Related]
15. Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
[No Abstract] [Full Text] [Related]
16. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
[TBL] [Abstract][Full Text] [Related]
17. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure.
Levy BI; Benessiano J; Henrion D; Caputo L; Heymes C; Duriez M; Poitevin P; Samuel JL
J Clin Invest; 1996 Jul; 98(2):418-25. PubMed ID: 8755652
[TBL] [Abstract][Full Text] [Related]
18. [Angiotensin II antagonists].
Tikkanen I; Tikkanen T
Duodecim; 1995; 111(18):1733-5. PubMed ID: 9340266
[No Abstract] [Full Text] [Related]
19. Angiotensin II antagonism: a new avenue of hypertension management.
Gavras H
Blood Press Suppl; 1997; 1():42-6. PubMed ID: 9285108
[TBL] [Abstract][Full Text] [Related]
20. Interaction between the natriuretic effects of renal perfusion pressure and the antinatriuretic effects of angiotensin and aldosterone in control of sodium excretion.
Young DB; Pan YJ
J Physiol (Paris); 1984; 79(6):511-7. PubMed ID: 6399318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
